A multicenter phase II study of nivolumab combined with ipilimumab in patients with pediatric solid tumours in adulthood (GETHI021)

dc.conference.dateSEP 19-OCT 18, 2020
dc.conference.titleESMO Virtual Congress
dc.contributor.authorMielgo Rubio, X.
dc.contributor.authorDiaz-Beveritge, R.
dc.contributor.authorSepulveda Sanchez, J. M.
dc.contributor.authorPineda, E.
dc.contributor.authorVaz Salgado, M. A.
dc.contributor.authorLecumberri, M. J.
dc.contributor.authorValverde, C.
dc.contributor.authorLopez Castro, R.
dc.contributor.authorLopez, C.
dc.contributor.authorVirizuela Echaburu, J. A.
dc.contributor.authorRodriguez Salas, N.
dc.contributor.authorde las Penas Bataller, R.
dc.contributor.authorLopez Lopez, R.
dc.contributor.authorMedina Rodriguez, J.
dc.contributor.authorRodriguez-Antona, C.
dc.contributor.authorBerraondo, P.
dc.contributor.authorRodriguez-Moreno, J. F.
dc.contributor.authorHurtado Nuno, A.
dc.contributor.authorSevillano, E.
dc.contributor.authorGarcia-Donas, J.
dc.contributor.authoraffiliation[Mielgo Rubio, X.] Hosp Univ Fdn Alcorcon, Med Oncol, Alcorcon, Spain
dc.contributor.authoraffiliation[Hurtado Nuno, A.] Hosp Univ Fdn Alcorcon, Med Oncol, Alcorcon, Spain
dc.contributor.authoraffiliation[Diaz-Beveritge, R.] Hosp Univ La Fe, Med Oncol, Valencia, Spain
dc.contributor.authoraffiliation[Sepulveda Sanchez, J. M.] Univ Hosp 12 Octubre, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Pineda, E.] Hosp Clin Barcelona, Med Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Vaz Salgado, M. A.] Hosp Univ Ramon Cajal, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Lecumberri, M. J.] Royal Navarre Hosp, Complejo Hosp Navarra, Med Oncol, Pamplona, Spain
dc.contributor.authoraffiliation[Valverde, C.] Vall dHebron Univ Hosp, Med Oncol Dept, Barcelona, Spain
dc.contributor.authoraffiliation[Lopez Castro, R.] Univ Clin Hosp Valladolid, Radiat & Med Oncol Dept, Valladolid, Spain
dc.contributor.authoraffiliation[Lopez, C.] Hosp Univ Marques Valdecilla, Med Oncol, Santander, Spain
dc.contributor.authoraffiliation[Virizuela Echaburu, J. A.] Hosp Univ Virgen Macarena, Med Oncol, Seville, Spain
dc.contributor.authoraffiliation[Rodriguez Salas, N.] Hosp Univ La Paz, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[de las Penas Bataller, R.] Hosp Prov Castellon, Med Oncol, Castellon de La Plana, Spain
dc.contributor.authoraffiliation[Lopez Lopez, R.] CHUS Complejo Hosp Univ Santiago de Composte, Med Oncol, Santiago De Compostela, Spain
dc.contributor.authoraffiliation[Medina Rodriguez, J.] Hosp Virgen de La Salud, Med Oncol, Toledo, Spain
dc.contributor.authoraffiliation[Rodriguez-Antona, C.] Spanish Natl Canc Res Ctr, Human Canc Genet Programme, Madrid, Spain
dc.contributor.authoraffiliation[Berraondo, P.] Royal Navarre Hosp, Complejo Hosp Navarra, Immunol Dept, Pamplona, Spain
dc.contributor.authoraffiliation[Rodriguez-Moreno, J. F.] Clara Campal Comprehens Canc Ctr, Madrid, Spain
dc.contributor.authoraffiliation[Sevillano, E.] Clara Campal Comprehens Canc Ctr, Madrid, Spain
dc.contributor.authoraffiliation[Garcia-Donas, J.] Ctr Integral Oncol Clara Campal, Madrid, Spain
dc.contributor.funderBMS
dc.date.accessioned2025-01-07T16:06:00Z
dc.date.available2025-01-07T16:06:00Z
dc.date.issued2020-09-01
dc.identifier.doi10.1016/j.annonc.2020.08.1189
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttp://www.annalsofoncology.org/article/S0923753420411858/pdf
dc.identifier.urihttps://hdl.handle.net/10668/27614
dc.identifier.wosID573469101357
dc.issue.number4
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen Macarena
dc.page.numberS727-S727
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleA multicenter phase II study of nivolumab combined with ipilimumab in patients with pediatric solid tumours in adulthood (GETHI021)
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number31
dc.wostypeMeeting Abstract

Files